Drug intelligence / Profile preview

gamaline + hipericin

Development stage
Unknown
Lead developer
Herbarium Laboratório Botânico
Administration
Oral
01

Overview

gamaline + hipericin is a phytotherapeutic combination consisting of standardized extracts of *Borago officinalis* (Borage oil, branded as Gamaline) and *Hypericum perforatum* (St. John's Wort, branded as Hipericin). Gamaline is rich in gamma-linolenic acid (GLA), a precursor to prostaglandin E1 (PGE1), which helps mitigate the inflammatory and hormonal fluctuations associated with premenstrual syndrome (PMS). Hipericin contains active compounds such as hypericin and hyperforin that act as non-selective reuptake inhibitors of serotonin, norepinephrine, and dopamine, providing antidepressant and anxiolytic effects. The combination was evaluated in Phase 3 clinical trials (NCT01365676 and NCT01283568) for the treatment of PMS and vasomotor symptoms in both reproductive-age and premenopausal women, aiming to address both the physical and psychological components of these conditions.

Brand names
GamalineHipericin
Other names
Borage oil + St. John's Wort extractGamma-linolenic acid + Hypericum perforatum extract
02

Targets

σR (Sigma receptors)SERT (Sodium-dependent serotonin transporter)DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on gamaline + hipericin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gamaline + hipericin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call